12:00 AM
Nov 11, 2013
 |  BC Week In Review  |  Company News  |  Other News

Nuvo, Mallinckrodt autoimmune news

In August, Nuvo filed a suit in the U.S. District Court for the Southern District of New York alleging partner Mallinckrodt breached its contractual obligations under a 2009 deal granting Mallinckrodt U.S. rights to Pennsaid diclofenac and a second-generation version of Pennsaid - Pennsaid Plus. In the suit, Nuvo Research Inc. v. Mallinckrodt Inc., Nuvo alleged that Mallinckrodt failed to initiate Phase III trials for Pennsaid Plus and failed to...

Read the full 337 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >